Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) shares shot up 14.7% on Friday . The stock traded as high as C$0.20 and last traded at C$0.20. 485,000 shares were traded during trading, an increase of 25% from the average session volume of 389,063 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a market cap of C$27.20 million, a price-to-earnings ratio of -19.50 and a beta of 0.32. The stock has a fifty day simple moving average of C$0.09 and a two-hundred day simple moving average of C$0.07.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Read More
- Five stocks we like better than Voyageur Pharmaceuticals
- 3 Best Fintech Stocks for a Portfolio Boost
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- What is Put Option Volume?
- 3 Buy-and-Hold Stocks for Long-Term Growth
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
